Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
p38α, also known as MAPK14, is a serine/threonine protein kinase and a member of the mitogen-activated protein kinase (MAPK) family. It plays a central role in cellular responses to stress and inflammation, integrating multiple external cues to regulate diverse cellular functions. p38α is ubiquitously expressed in human tissues and is the most widely studied isoform among the four p38 MAPKs: p38α (MAPK14), p38β (MAPK11), p38γ (MAPK12), and p38δ (MAPK13).
Inhibition of ATP binding to p38α kinase domain
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on p38α Mitogen-Activated Protein Kinase (p38α).